Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
Objective: Medication-related osteonecrosis of the jaw (MRONJ), a complication of bisphosphonate therapy, has significant morbidity. This study aimed to determine the prevalence of MRONJ and compare its risks among patients who received antiresorptive or antiangiogenic therapy in King Fahad Medical...
Saved in:
| Main Authors: | Saad Hajeri, BDS, Yasir Alturkistany, BDS, MBA |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2022-09-01
|
| Series: | Saudi Dental Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S101390522200075X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ONJ (MRONJ) Update 2024: Osteonecrosis of the Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment—A National Italian Symposium
by: Vittorio Fusco, et al.
Published: (2025-04-01) -
Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population
by: Miika Kujanpää, et al.
Published: (2025-05-01) -
Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
by: Rial Seluki, et al.
Published: (2023-12-01) -
Risk of Osteonecrosis of the Jaw in Patients Treated with Zoledronic or Alendronic Acid: A Systematic Review
by: Aine Jakonyte, et al.
Published: (2025-06-01) -
Effects of discontinuing different antiresorptive regimens on medication-related osteonecrosis of the jaw in patients undergoing dental procedures: a systematic review and network meta-analysis
by: Kasidid Ruksakiet, et al.
Published: (2025-05-01)